Please login to the form below

Not currently logged in
Email:
Password:

Pfizer plans four-part bond sale

Pfizer plans to raise $10.6bn from the sale of a four-part bond denominated in euros and sterling, according to a banker involved in the deal

Pfizer Inc plans to raise $10.6bn from the sale of a four-part bond denominated in euros and sterling, according to a banker involved in the deal.

The US pharmaceutical giant is selling €1.85bn of four-year bonds, €2bn of seven-year notes, and €2bn of 12-year debt. The New York company is also issuing £1.5bn of debt due in 2038.

The sale follows Pfizer's launch and completion of a five-part $13.5bn debt deal in the US. The proceeds will help fund Pfizer's $68bn takeover of Wyeth.

Pharma companies are tapping the debt markets to finance mergers and acquisitions, taking advantage of investor appetite for investment-grade corporate bonds.

Drugmakers and healthcare service providers have offered $20bn of bonds in euros and sterling this year, compared with an equivalent $1.2bn in all of 2008, according to data compiled by Bloomberg.

Bank of America/Merrill Lynch, Barclays, Citigroup, Goldman Sachs and JP Morgan are managing the sale of the Pfizer bond.

27th May 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics